Methods | RCT with baseline period, followed by cross‐over design Method of randomisation: not stated Blinding of outcome assessors: stated as 'yes' by the investigator Adverse events: not stated Deaths: not stated Drop outs: 10 (unclear in which period/group) ITT: unclear | |
Participants | Country: USA 30 participants (probably 15 in EXP group, 15 in CTL group) Ambulatory at study onset Mean age: 57 to 67 years (CTL and EXP group respectively) Inclusion criteria: ≤ 3 months after stroke, ability to stand or walk 5 metres Exclusion criteria: orthopaedic problems, contractures, NYHA III‐IV | |
Interventions | 2 arms: A, A‐B, B‐A 20 out of 30 participants with chronic stroke completed a repeated baseline measure, randomised cross‐over trial in which walking performance was assessed during the last 4 weeks of clinical physical therapy before discharge secondary to reaching a plateau, followed by 4 weeks of intensive locomotor training and 4 weeks of no intervention |
|
Outcomes | Outcome measures included clinical and physiological (metabolic) measures of walking overground and on a treadmill, and measures of daily stepping activity in the home and community, including during clinical physical therapy and subsequent locomotor therapy sessions | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Method of randomisation not stated |
Allocation concealment (selection bias) | Unclear risk | Method not stated |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not stated |